Role of S-Iron and Ferritin to Predict the Response to Recent New Antiviral Treatment in Chronic Hepatitis C Patients

Serum Hepcidin In Patients With Chronic Hepatitis C And Its Relation To Treatment With Antiviral Drugs

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

Liver Fibrosis as a Predictive Factor of Response to Pegylated-IFN/ Ribavirin Therapy in Chronic HCV Patients

Serum Iron, Serum Ferritin and Hepatic Iron Content as a Predictive Values for Combined Therapy of Chronic Hepatitis C Patients

Predictive value &changes in Child-Pugh score in chronic hepatitis C cirrhotic patients treated with Direct Acting Antiviral agents

Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy

Serum Clusterin In Patients With Chronic HCV infection Related Cirrhosis

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Monitoring Hepcidin Level in Chronic Hepatitis C Virus Patients during Therapy